U.S. flag

An official website of the United States government

NM_003060.4(SLC22A5):c.44G>A (p.Gly15Glu) AND Renal carnitine transport defect

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Oct 24, 2022
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001376870.9

Allele description [Variation Report for NM_003060.4(SLC22A5):c.44G>A (p.Gly15Glu)]

NM_003060.4(SLC22A5):c.44G>A (p.Gly15Glu)

Gene:
SLC22A5:solute carrier family 22 member 5 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5q31.1
Genomic location:
Preferred name:
NM_003060.4(SLC22A5):c.44G>A (p.Gly15Glu)
Other names:
p.Gly15Glu
HGVS:
  • NC_000005.10:g.132370016G>A
  • NG_008982.2:g.5313G>A
  • NM_001308122.2:c.44G>A
  • NM_003060.4:c.44G>AMANE SELECT
  • NP_001295051.1:p.Gly15Glu
  • NP_003051.1:p.Gly15Glu
  • NC_000005.9:g.131705708G>A
Protein change:
G15E
Links:
dbSNP: rs751129547
NCBI 1000 Genomes Browser:
rs751129547
Molecular consequence:
  • NM_001308122.2:c.44G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_003060.4:c.44G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Renal carnitine transport defect (CDSP)
Synonyms:
CARNITINE TRANSPORTER, PLASMA-MEMBRANE, DEFICIENCY OF; Primary carnitine deficiency; Carnitine uptake defect; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008919; MedGen: C0342788; Orphanet: 158; OMIM: 212140

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001574056Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Oct 24, 2022)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

SCV002576662Giacomini Lab, University of California, San Francisco
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Oct 3, 2022)
germline, not applicableresearch, in vitro

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, research
not providednot applicablenot applicablenot providednot providednot providednot providednot providedin vitro

Citations

PubMed

Maternal systemic primary carnitine deficiency uncovered by newborn screening: clinical, biochemical, and molecular aspects.

El-Hattab AW, Li FY, Shen J, Powell BR, Bawle EV, Adams DJ, Wahl E, Kobori JA, Graham B, Scaglia F, Wong LJ.

Genet Med. 2010 Jan;12(1):19-24. doi: 10.1097/GIM.0b013e3181c5e6f7.

PubMed [citation]
PMID:
20027113

Molecular spectrum of SLC22A5 (OCTN2) gene mutations detected in 143 subjects evaluated for systemic carnitine deficiency.

Li FY, El-Hattab AW, Bawle EV, Boles RG, Schmitt ES, Scaglia F, Wong LJ.

Hum Mutat. 2010 Aug;31(8):E1632-51. doi: 10.1002/humu.21311.

PubMed [citation]
PMID:
20574985
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001574056.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 15 of the SLC22A5 protein (p.Gly15Glu). This variant is present in population databases (rs751129547, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with SLC22A5-related conditions. ClinVar contains an entry for this variant (Variation ID: 1065994). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC22A5 protein function. This variant disrupts the p.Gly15 amino acid residue in SLC22A5. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 20027113, 20574985, 21922592). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Giacomini Lab, University of California, San Francisco, SCV002576662.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearch PubMed (1)
2not providednot providednot providednot providedin vitro PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided
2not applicablenot applicablenot providednot providedassert pathogenicitynot providednot providednot providednot provided

Last Updated: Sep 29, 2024